NCT06820983 Evaluation of the Quality of Life of Patients With DBB With the Installation of OPEP
| NCT ID | NCT06820983 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Centre Hospitalier Universitaire, Amiens |
| Condition | Bronchiectasis |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2024-10-17 |
| Primary Completion | 2026-04 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2024-10-17 with a primary completion date of 2026-04.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To carry out an assessment of compliance and quality of life in a population (children and adults) with DDB before and after the use of an oscillating PEP. The aim is to determine the impact of the use of oscillating PEP on the daily life of this population in particular.
Eligibility Criteria
Inclusion Criteria: * Children (from 8 years of age) and adults over 18 years of age with DDB who doesn't use oscillating PEP. The study population will be clinically stable and will be seen in follow-up consultations. Exclusion Criteria: * Children under 8 years of age. * Patients who use an OPEP * Patients in the acute exacerbation phase of their DDB * Patients who are not under regular consultation * Patients with severe, uncontrolled co-morbidities * Patients with cognitive or psychiatric disorders preventing proper adherence to the study protocol * Patients taking part simultaneously in another clinical study that could interfere with the results of the OPEP study
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06820983 clinical trial?
This trial is open to participants of all sexes, aged 8 Years or older, studying Bronchiectasis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06820983 currently recruiting?
Yes, NCT06820983 is actively recruiting participants. Contact the research team at pinto.thomas@chu-amiens.fr for enrollment information.
Where is the NCT06820983 trial being conducted?
This trial is being conducted at Amiens, France.
Who is sponsoring the NCT06820983 clinical trial?
NCT06820983 is sponsored by Centre Hospitalier Universitaire, Amiens. The trial plans to enroll 60 participants.